Veraxa Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
1.475
+0.005 (0.34%)
At close: Sep 18, 2026, 4:00 PM EDT
1.460
-0.015 (-1.02%)
After-hours: Sep 18, 2026, 4:10 PM EDT
Veraxa Biotech AG Market Cap
Veraxa Biotech AG has a market cap or net worth of $206.46 million as of September 18, 2026. Its market cap has decreased by -37.47% in one year.
Market Cap
206.46M
Enterprise Value
205.86M
1-Year Change
-37.47%
Ranking
Category
Stock Price
$1.48
ChartMarket Cap Chart
Since September 30, 2024, Veraxa Biotech AG's market cap has decreased from $315.30M to $206.46M, a decrease of -34.52%. That is a compound annual growth rate of -19.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 206.46M | -38.82% |
| Dec 31, 2025 | 337.44M | 6.49% |
| Dec 30, 2024 | 316.88M | 0.50% |
| Sep 30, 2024 | 315.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adagene | 224.93M |
| Anavex Life Sciences | 224.33M |
| Invivyd | 221.57M |
| Keros Therapeutics | 218.69M |
| Protara Therapeutics | 217.47M |
| Protalix BioTherapeutics | 217.14M |
| Eledon Pharmaceuticals | 214.74M |
| Sol-Gel Technologies | 210.62M |